Third Report - My Science Inquiry
- HC No.
- HC 618
- Published
- 8 Nov 2022
- Items
- 0
- Response
- No response document linked
Select Committee · Science and Technology Committee (Commons)
My Science Inquiry
Status: Closed
Opened: 12 Jul 2022
Closed: 13 Apr 2023
1 report
Inquiry scope
The Commons Science and Technology Committee has today launched an open call for potential topics of inquiry in the areas of science and technology. ‘My Science Inquiry’ invites proposals on what the Committee should investigate next and why, including what action is needed from the Government. Up to 10 individuals will then be invited to pitch their proposal to MPs on the Committee in a public session. The winning proposal will form the basis of a new inquiry by the Committee. The Committee seeks ideas for inquiries from the science, research and innovation communities as well as the wider public. It particularly wants to hear from members of underrepresented groups in STEM. Previous ‘My Science’ inquiries were held in 2017 and 2019 and gathered over 160 inquiry ideas. ‘Algorithms in decision-making’ and ‘E-cigarettes’ were two inquiries taken forward from that process and completed by the predecessor Committee. The current Committee’s work on ‘Commercial genomics’ was also originally instigated by a My Science Inquiry proposal. Join the conversation on Twitter using #MyScienceInquiryReports
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 19 Oct 2022 |
Pitch One; Pitch Two; Pitch Three; Pitch Four; Pannel Five; Pannel Six
Andrea Lucard · Medicines for Malaria Ventures,
Dr Sarah Gordon · Satarla,
James Dowden · University of Nottingham,
James Ebdon · Applied Microbiology International (formerly Society for Applied Microbiology),
Louise Jones · The Royal College of Pathologists Digital Pathology Committee,
Professor Jo Slater-Jefferies · National Biofilms Innovation Centre
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Andrea Lucard · Executive Vice President | Medicines for Malaria Ventures | 1 |
| Dr Sarah Gordon · Chief Executive Office | Satarla | 1 |
| James Dowden · Associate Professor in Synthetic Chemistry | University of Nottingham | 1 |
| James Ebdon · Member | Applied Microbiology International (formerly Society for Applied Microbiology) | 1 |
| Louise Jones · Chair of the Genomics and Reproductive Science Specialist Advisory Committee | The Royal College of Pathologists Digital Pathology Committee | 1 |
| Professor Jo Slater-Jefferies · Chief Executive Office | National Biofilms Innovation Centre | 1 |